China Biologic Products Company Profile (NASDAQ:CBPO)

About China Biologic Products (NASDAQ:CBPO)

China Biologic Products logoChina Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories. The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC). It is developing Human fibrinogen, Immune Globulin Intravenous (Human), Human Antithrombin III (concentration), Human coagulation factor IX, Human Cytomegalovirus Immunoglobulin and Human Fibrin Sealant.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CBPO
  • CUSIP: N/A
  • Web: www.chinabiologic.com
Capitalization:
  • Market Cap: $3.11 billion
  • Outstanding Shares: 27,201,000
Average Prices:
  • 50 Day Moving Avg: $113.47
  • 200 Day Moving Avg: $110.67
  • 52 Week Range: $96.99 - $137.38
P/E:
  • Trailing P/E Ratio: 29.60
  • Foreward P/E Ratio: 19.30
  • P/E Growth: 1.60
Sales & Book Value:
  • Annual Revenue: $347.03 million
  • Price / Sales: 8.96
  • Book Value: $18.48 per share
  • Price / Book: 6.18
Profitability:
  • EBIDTA: $158.57 million
  • Net Margins: 30.63%
  • Return on Equity: 19.61%
  • Return on Assets: 17.04%
Debt:
  • Current Ratio: 6.01%
  • Quick Ratio: 3.98%
Misc:
  • Average Volume: 217,070 shs.
  • Beta: 1.78
  • Short Ratio: 4.84
 

Frequently Asked Questions for China Biologic Products (NASDAQ:CBPO)

What is China Biologic Products' stock symbol?

China Biologic Products trades on the NASDAQ under the ticker symbol "CBPO."

How were China Biologic Products' earnings last quarter?

China Biologic Products Inc (NASDAQ:CBPO) released its quarterly earnings data on Thursday, February, 23rd. The company reported $0.95 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.11. The company earned $77.60 million during the quarter, compared to analyst estimates of $76.61 million. China Biologic Products had a net margin of 30.63% and a return on equity of 19.61%. China Biologic Products's revenue was up 13.6% compared to the same quarter last year. During the same period last year, the business earned $0.74 earnings per share. View China Biologic Products' Earnings History.

When will China Biologic Products make its next earnings announcement?

China Biologic Products is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for China Biologic Products.

Where is China Biologic Products' stock going? Where will China Biologic Products' stock price be in 2017?

3 equities research analysts have issued 1-year price targets for China Biologic Products' shares. Their predictions range from $128.00 to $135.00. On average, they expect China Biologic Products' share price to reach $131.50 in the next year. View Analyst Ratings for China Biologic Products.

Are investors shorting China Biologic Products?

China Biologic Products saw a increase in short interest in the month of April. As of April 28th, there was short interest totalling 1,801,192 shares, an increase of 6.5% from the April 13th total of 1,690,750 shares. Based on an average daily volume of 212,352 shares, the short-interest ratio is presently 8.5 days.

Who are some of China Biologic Products' key competitors?

Who owns China Biologic Products stock?

China Biologic Products' stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (6.91%), BlackRock Inc. (5.54%), Baillie Gifford & Co. (5.13%), FIL Ltd (3.23%), Hermes Investment Management Ltd. (2.32%) and Bank of New York Mellon Corp (2.07%). Company insiders that own China Biologic Products stock include David Gao, Ming Yang, Ming Yin, Sean Shao, Wenfang Liu, Wp X Biologics Llc, Zhijing Cbpo Liu and Zhijun Tong. View Institutional Ownership Trends for China Biologic Products.

Who sold China Biologic Products stock? Who is selling China Biologic Products stock?

China Biologic Products' stock was sold by a variety of institutional investors in the last quarter, including Mirae Asset Global Investments Co. Ltd., Credit Suisse AG, SPQ Asia Capital Ltd, Cornerstone Capital Management Holdings LLC., BARING ASSET MANAGEMENT Ltd, Ativo Capital Management LLC, Baillie Gifford & Co. and Envestnet Asset Management Inc.. Company insiders that have sold China Biologic Products stock in the last year include David Gao, Ming Yang, Sean Shao, Wenfang Liu, Wp X Biologics Llc and Zhijing Cbpo Liu. View Insider Buying and Selling for China Biologic Products.

Who bought China Biologic Products stock? Who is buying China Biologic Products stock?

China Biologic Products' stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, Hermes Investment Management Ltd., Macquarie Group Ltd., Artisan Partners Limited Partnership, Alliancebernstein L.P., MARSHALL WACE ASIA Ltd and Marshall Wace North America L.P.. View Insider Buying and Selling for China Biologic Products.

How do I buy China Biologic Products stock?

Shares of China Biologic Products can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of China Biologic Products stock cost?

One share of China Biologic Products stock can currently be purchased for approximately $114.28.

Analyst Ratings

Consensus Ratings for China Biologic Products (NASDAQ:CBPO) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $131.50 (15.07% upside)

Analysts' Ratings History for China Biologic Products (NASDAQ:CBPO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/3/2017Morgan StanleyReiterated RatingOverweight$135.00N/AView Rating Details
2/27/2017Jefferies Group LLCSet Price TargetBuy$128.00N/AView Rating Details
7/5/2016Credit Suisse Group AGUpgradeNeutral -> OutperformN/AView Rating Details
1/7/2016Deutsche Bank AGBoost Price TargetBuy$149.00 -> $162.00N/AView Rating Details
7/9/2015Bank of America CorpInitiated CoverageBuy$135.00N/AView Rating Details
(Data available from 5/27/2015 forward)

Earnings

Earnings History for China Biologic Products (NASDAQ:CBPO)
Earnings by Quarter for China Biologic Products (NASDAQ:CBPO)
Earnings History by Quarter for China Biologic Products (NASDAQ:CBPO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2017        
2/23/2017Q416$0.84$0.95$76.61 million$77.60 millionViewN/AView Earnings Details
11/2/2016Q316$1.05$1.22$88.46 million$86.50 millionViewN/AView Earnings Details
8/4/2016Q216$1.16$1.10$87.60 million$91.40 millionViewN/AView Earnings Details
5/4/2016Q116$0.88$0.94$74.00 million$85.60 millionViewN/AView Earnings Details
2/25/2016Q415$0.55$0.74$66.77 million$68.30 millionViewListenView Earnings Details
11/3/2015Q315$0.81$0.82$75.30 million$78.80 millionViewN/AView Earnings Details
8/5/2015Q215$0.87$0.99$71.75 million$79.10 millionViewN/AView Earnings Details
5/6/2015Q1 15$0.84$0.87$70.35 millionViewN/AView Earnings Details
11/5/2014Q4 14$0.43$0.48$63.00 million$68.92 millionViewN/AView Earnings Details
3/12/2014Q413$0.38$0.35$41.50 million$42.60 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.56$47.20 million$53.20 millionViewN/AView Earnings Details
11/8/2012Q312$0.54$41.30 million$53.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for China Biologic Products (NASDAQ:CBPO)
Current Year EPS Consensus Estimate: $5.09 EPS
Next Year EPS Consensus Estimate: $5.92 EPS

Dividends

Dividend History for China Biologic Products (NASDAQ:CBPO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for China Biologic Products (NASDAQ:CBPO)
Insider Ownership Percentage: 2.68%
Institutional Ownership Percentage: 69.86%
Insider Trades by Quarter for China Biologic Products (NASDAQ:CBPO)
Institutional Ownership by Quarter for China Biologic Products (NASDAQ:CBPO)
Insider Trades by Quarter for China Biologic Products (NASDAQ:CBPO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2017Zhijing Cbpo LiuInsiderSell7,500$116.49$873,675.00View SEC Filing  
3/2/2017Sean ShaoDirectorSell20,000$100.78$2,015,600.00View SEC Filing  
3/1/2017David GaoCEOSell116,653$100.63$11,738,791.39View SEC Filing  
8/15/2016Ming YangCFOSell21,092$124.32$2,622,157.44View SEC Filing  
8/15/2016Wenfang LiuDirectorSell2,900$124.32$360,528.00View SEC Filing  
8/15/2016Zhijing Cbpo LiuInsiderSell1,968$124.32$244,661.76View SEC Filing  
6/8/2016Wp X Biologics LlcDirectorSell2,775,000$111.00$308,025,000.00View SEC Filing  
5/20/2016Ming YangCFOSell13,908$113.64$1,580,505.12View SEC Filing  
5/20/2016Ming YinVPSell19,618$113.64$2,229,389.52View SEC Filing  
3/11/2016Zhijing Cbpo LiuVPSell282$108.00$30,456.00View SEC Filing  
3/7/2016Wp X Biologics LlcDirectorSell4,257,000$107.00$455,499,000.00View SEC Filing  
12/7/2015Zhijun TongDirectorSell15,000$118.33$1,774,950.00View SEC Filing  
11/4/2015David GaoCEOSell95,991$115.60$11,096,559.60View SEC Filing  
11/2/2015David GaoCEOSell12,891$112.26$1,447,143.66View SEC Filing  
10/29/2015David GaoCEOSell71,118$110.21$7,837,914.78View SEC Filing  
10/26/2015David GaoCEOSell59,542$105.22$6,265,009.24View SEC Filing  
10/20/2015David GaoCEOSell258$105.00$27,090.00View SEC Filing  
10/19/2015David GaoCEOSell200$105.03$21,006.00View SEC Filing  
9/15/2015Ming YangCFOSell9,000$94.56$851,040.00View SEC Filing  
9/15/2015Ming YinVPSell20,508$95.55$1,959,539.40View SEC Filing  
9/14/2015Ming YangCFOSell11,304$97.08$1,097,392.32View SEC Filing  
9/14/2015Wenfang LiuDirectorSell2,717$97.02$263,603.34View SEC Filing  
9/14/2015Zhijing Cbpo LiuVPSell6,786$99.29$673,781.94View SEC Filing  
6/15/2015Wp X Biologics LlcDirectorSell2,645,000$100.28$265,240,600.00View SEC Filing  
11/21/2014Zhijing Cbpo LiuVPSell8,000$68.95$551,600.00View SEC Filing  
11/10/2014Sean ShaoDirectorSell72,500$62.75$4,549,375.00View SEC Filing  
11/10/2014Zhijing Cbpo LiuVPSell7,500$62.75$470,625.00View SEC Filing  
9/15/2014Gang Cbpo YangVPSell2,454$54.00$132,516.00View SEC Filing  
9/15/2014Ming YangCFOSell6,164$54.00$332,856.00View SEC Filing  
9/12/2014Ming YinVPSell3,073$54.00$165,942.00View SEC Filing  
9/12/2013Wenfang LiuDirectorSell2,524$25.00$63,100.00View SEC Filing  
5/14/2013Wp X Biologics LlcDirectorBuy3,112,920$20.00$62,258,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for China Biologic Products (NASDAQ:CBPO)
Latest Headlines for China Biologic Products (NASDAQ:CBPO)
Source:
DateHeadline
finance.yahoo.com logoChina Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders
finance.yahoo.com - May 19 at 9:06 PM
americanbankingnews.com logoChina Biologic Products Inc (CBPO) Short Interest Update
www.americanbankingnews.com - May 19 at 8:26 PM
americanbankingnews.com logoZacks: Analysts Set $135.67 Price Target for China Biologic Products Inc (CBPO)
www.americanbankingnews.com - May 12 at 8:52 PM
nasdaq.com logoChina Biologic Products (CBPO) Shares Cross Below 200 DMA
www.nasdaq.com - May 11 at 4:48 PM
americanbankingnews.com logoChina Biologic Products Inc (CBPO) Insider Sells $873,675.00 in Stock
www.americanbankingnews.com - May 10 at 11:03 PM
seekingalpha.com logoChina Biologic Products' (CBPO) CEO David Gao on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 8 at 4:05 PM
americanbankingnews.com logoJefferies Group Comments on China Biologic Products Inc's FY2018 Earnings (CBPO)
www.americanbankingnews.com - May 8 at 11:58 AM
americanbankingnews.com logoZacks Investment Research Downgrades China Biologic Products Inc (CBPO) to Sell
www.americanbankingnews.com - May 5 at 7:38 PM
finance.yahoo.com logoThis Chinese Pharma Stock Has 20% Upside
finance.yahoo.com - May 5 at 2:20 AM
finance.yahoo.com logoEdited Transcript of CBPO earnings conference call or presentation 4-May-17 11:30am GMT
finance.yahoo.com - May 4 at 9:20 PM
finance.yahoo.com logoChina Biologic Products posts 1Q profit - Yahoo Finance
finance.yahoo.com - May 4 at 4:19 PM
finance.yahoo.com logoChina Biologic Products posts 1Q profit
finance.yahoo.com - May 4 at 4:19 PM
finance.yahoo.com logoInvestor Network: China Biologic Products, Inc. to Host Earnings Call
finance.yahoo.com - May 4 at 4:19 PM
finance.yahoo.com logoChina Biologic Reports Financial Results for the First Quarter of 2017 - Yahoo Finance
finance.yahoo.com - May 4 at 2:14 AM
reuters.com logoBRIEF-China Biologic reports Q1 earnings per share $1.06
www.reuters.com - May 3 at 9:13 PM
finance.yahoo.com logoChina Biologic Reports Financial Results for the First Quarter of 2017
finance.yahoo.com - May 3 at 9:13 PM
americanbankingnews.com logo$1.24 Earnings Per Share Expected for China Biologic Products Inc (CBPO) This Quarter
www.americanbankingnews.com - May 1 at 1:52 PM
americanbankingnews.com logoChina Biologic Products (CBPO) Receiving Favorable News Coverage, Analysis Finds
www.americanbankingnews.com - April 29 at 10:54 AM
americanbankingnews.com logoChina Biologic Products (CBPO) Receives Media Impact Score of 0.17
www.americanbankingnews.com - April 25 at 3:58 PM
americanbankingnews.com logoBrokerages Expect China Biologic Products Inc (CBPO) to Announce $1.24 EPS
www.americanbankingnews.com - April 24 at 7:56 PM
americanbankingnews.com logoFavorable News Coverage Likely to Impact China Biologic Products (CBPO) Stock Price
www.americanbankingnews.com - April 22 at 12:53 PM
finance.yahoo.com logoChina Biologic Products to Report First Quarter of 2017 Financial Results
finance.yahoo.com - April 21 at 4:17 PM
nasdaq.com logoCBPO Crosses Above Key Moving Average Level
www.nasdaq.com - April 19 at 1:01 PM
americanbankingnews.com logoChina Biologic Products (CBPO) Earning Very Favorable News Coverage, Study Shows
www.americanbankingnews.com - April 18 at 9:26 AM
americanbankingnews.com logoChina Biologic Products (CBPO) Receiving Favorable News Coverage, Report Shows
www.americanbankingnews.com - April 15 at 10:29 AM
finance.yahoo.com logoChina Biologic Products, Inc. – Value Analysis (NASDAQ:CBPO) : April 12, 2017
finance.yahoo.com - April 12 at 4:09 PM
americanbankingnews.com logoZacks: Brokerages Expect China Biologic Products Inc (CBPO) Will Post Quarterly Sales of $0.00
www.americanbankingnews.com - April 12 at 12:37 PM
finance.yahoo.com logoChina Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : April 11, 2017
finance.yahoo.com - April 11 at 10:05 AM
finance.yahoo.com logoETFs with exposure to China Biologic Products, Inc. : April 7, 2017
finance.yahoo.com - April 7 at 4:10 PM
americanbankingnews.com logoZacks: Brokerages Set $131.67 Price Target for China Biologic Products Inc (CBPO)
www.americanbankingnews.com - April 6 at 8:45 PM
americanbankingnews.com logo Analysts Set $131.67 Target Price for China Biologic Products Inc (CBPO)
www.americanbankingnews.com - March 22 at 10:26 AM
finance.yahoo.com logoCHINA BIOLOGIC PRODUCTS, INC. Financials
finance.yahoo.com - March 2 at 4:22 PM
nasdaq.com logoChina Biologic Products Becomes Oversold (CBPO)
www.nasdaq.com - March 1 at 10:29 AM
seekingalpha.com logoChina Biologic Products' (CBPO) CEO David Gao on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - February 25 at 3:59 PM
finance.yahoo.com logoEdited Transcript of CBPO earnings conference call or presentation 24-Feb-17 12:30pm GMT
finance.yahoo.com - February 24 at 9:21 PM
reuters.com logoBRIEF-China Biologic Q4 adjusted non-GAAP earnings per share $0.95
www.reuters.com - February 24 at 12:42 PM
biz.yahoo.com logoCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 10-K, Annual Report
us.rd.yahoo.com - February 24 at 12:42 PM
us.rd.yahoo.com logoChina Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016
us.rd.yahoo.com - February 24 at 12:42 PM
us.rd.yahoo.com logo5:07 pm China Biologic Products beats by $0.01, reports revs in-line; gudes FY17
us.rd.yahoo.com - February 24 at 12:42 PM
nasdaq.com logoChina Biologic Products Inc. Bottom Line Advances 31% In Q4 - Nasdaq
www.nasdaq.com - February 23 at 9:09 PM
biz.yahoo.com logoQ4 2016 China Biologic Products Inc Earnings Release - After Market Close
biz.yahoo.com - February 23 at 4:07 PM
finance.yahoo.com logoChina Biologic Products to Report Fourth Quarter and Fiscal Year 2016 Financial Results
finance.yahoo.com - February 14 at 4:55 PM
nasdaq.com logoWestpac Banking Corp Buys Alibaba Group Holding, US Silica Holdings, Arconic, Sells Edwards ...
www.nasdaq.com - February 10 at 3:48 PM
seekingalpha.com logoChina Biologic Has A Wide Moat And Hedges Geographic Risk
seekingalpha.com - February 3 at 4:23 PM
nasdaq.com logoAnalysts Expect FNI Will Reach $34
www.nasdaq.com - January 24 at 4:43 PM
finance.yahoo.com logoNew Strong Sell Stocks for January 18th
finance.yahoo.com - January 18 at 3:17 PM
biz.yahoo.com logoCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - January 6 at 4:31 PM
biz.yahoo.com logoCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - January 4 at 5:11 PM
streetinsider.com logoChina Cord Blood (CO) Shareholder Heng Ren Seeks $3.13/Share Special Dividend
www.streetinsider.com - December 15 at 9:35 PM
nasdaq.com logoCBPO Makes Notable Cross Below Critical Moving Average
www.nasdaq.com - December 2 at 9:34 PM

Social

Chart

China Biologic Products (CBPO) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff